<< Back to CIMZIA.com
CIMZIA

Site Map

Crohn's Disease Patients & Caregivers

  • About Crohn's Disease
  • About CIMZIA
  • Talking to Your Doctor
  • Learn More Today
  • Resources
  • Side Effects
  • About UCB

Crohn's Disease Healthcare Professionals

  • Crohn's Disease in the Clinical Setting
  • About CIMZIA
  • Clinical Trials Overview
  • Patient Support
  • Safety Information
  • Resources

Rheumatoid Arthritis Patients & Caregivers

  • Medication Guide & Prescribing Information
  • About Rheumatoid Arthritis
  • About Cimzia®
  • Prefilled Syringe Designed in Partnership with OXO GoodGrips®
  • Ready to Talk to Your Doctor
  • Side Effects
  • Important Safety Information
  • Learn More Today

Rheumatoid Arthritis Healthcare Professionals

  • Rheumatoid Arthritis Information for Healthcare Professionals
  • About Pegylation
  • The Rapid 1 Trial
  • The Fast4Ward Trial
  • Dosing & Administration
  • Adverse Events
  • Important Safety Information

CIMplicity

  • CIMplicity for Patients
  • CIMplicity for HCPs
  • Program Terms & Conditions
  • CIMpay® Card Activation & Request

Risk Evaluation and Mitigation Strategy (REMS)

  • Dear Doctor Letter
  • Medication Guide
  • Prescribing Information
  • Medical Science Liaison presentation (MSL Deck)
  • Brief Summary of Histoplasmosis



This site is intended for US residents.

CIMZIA.com | Medication Guide & Prescribing Information | Privacy Policy | Terms of Use | About UCB | Site Map © 2009 UCB, Inc. All rights reserved.

CIMZIA®, CIMplicity™, CIMpay® are trademarks of the UCB Group of Companies.

OXO, GOOD GRIPS and the associated logos are trademarks of Helen of Troy Limited and are used under license.





You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information Regarding Fungal Infections

Unsubscribe